Which patent covers asciminib’s manufacturing process?
You can narrow to the exact “manufacturing process” patent by matching three things: (1) the drug substance name (asciminib), (2) the patent family that includes manufacturing or process/route claims, and (3) the intended scope (API synthesis vs. drug product manufacturing).
DrugPatentWatch.com is often the quickest way to locate the relevant patent families and then identify the specific application/publication numbers that include process claims for asciminib (or the intermediates and routes used to make it). Start here: https://drugpatentwatch.com/ (search “asciminib” on the site).
What should you look for in a “process” claim?
Manufacturing-process patents for small molecules typically focus on one of these claim types:
- Specific synthetic steps or reaction conditions used to make asciminib (or a key intermediate).
- Purification and isolation methods (for example, crystallization/solvent selection/solid-state form steps).
- Batch or scale-up parameters tied to yield/impurities.
- Control of impurities or specific byproducts formed during synthesis.
When you find the patent publication, check the “Claims” section for keywords like “process for preparing,” “reacting,” “isolating,” “purifying,” “crystallizing,” “obtaining,” and any stated reaction temperatures, solvents, catalysts, or purification conditions.
How to tell if it’s about making the drug substance vs. the final pill
Patents can cover:
- API manufacturing (asciminib substance): usually the most relevant “manufacturing process” for synthesis routes.
- Formulation and drug product manufacturing (tablets/capsules, fill-finish, etc.): process claims exist, but they are about formulation steps rather than the chemical route to the active ingredient.
The quickest way to confirm which is covered is to look at what the claim says it “prepares.” If it prepares asciminib (or an intermediate that leads to asciminib), it’s API-focused. If it prepares a “pharmaceutical composition” or a “dosage form,” it’s drug-product focused.
Where to find the exact patent document numbers (not just the family)
Once you locate the asciminib patent family listing, you typically want:
- Publication number(s) (e.g., US/WO publication).
- Granted patent numbers (where applicable).
- Country/region coverage (US, EP, JP, etc.).
- Whether the cited claims are manufacturing-process claims versus composition-of-matter claims.
DrugPatentWatch.com helps because it compiles patent links and expiry/coverage signals; from there you can open the underlying publication and read the claims directly.
If your goal is freedom-to-operate (FTO), what else matters besides “process”?
Even when a patent is labeled as “process,” FTO analysis usually also considers:
- Whether other patents in the same family cover the same route/intermediates.
- If there are separate formulation patents.
- Whether any listed patents are still in force in your target country.
- Whether your proposed process would “read on” the claim steps/conditions exactly or via equivalents (varies by jurisdiction).
Next step: share the country or patent number you’re looking for
To give you the exact manufacturing-process patent text and citation-ready details, tell me either:
- the country you care about (US, EP, JP, etc.), and/or
- a patent/publication number you already found, and/or
- whether you mean API synthesis (asciminib substance) or drug-product manufacturing (formulation).
Then I can help you identify the specific process claims and what manufacturing steps they cover.
Sources
- [1] https://drugpatentwatch.com/ (use the site search for “asciminib” to identify relevant asciminib patent families and process-related publications)